Futurity -- CARNEGIE MELLON (US)/MCGILL (CAN) — The up and down success of drug trials may be due to a kind of myopia in which overly optimistic predictions result from narrowly focusing on a new drug’s performance in pre-clinical studies.
Futurity -- CARNEGIE MELLON (US)/MCGILL (CAN) — The up and down success of drug trials may be due to a kind of myopia in which overly optimistic predictions result from narrowly focusing on a new drug’s performance in pre-clinical studies.
